both Pharming and GTC use transgenic mammals to produce complex therapeutic proteins. Many are watching as these proteins go thru the regulatory process. Rhucin by Pharming is the most recent to have an opinion rendered (by the EMEA)
IMO, the negative EMEA opinion on Rhucin added to the downward pressure on GTC PPS. And a reversal of the opinion (possibly in late 2008) will boost GTC.
Best Wishes /
The creation of a thousand forests is in one acorn.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.